Brain Amyloid Pathology and Cognitive Function - Alzheimer Disease Without Dementia?
14 Jun 2017
If there ever was an exciting time for Alzheimer disease (AD) research, it is now. The discovery of biomarkers beginning 20 years ago, for example, positron emission tomography (PET) tracers that bind to plaques, the core pathological hallmark of the disease, unlocked new research fields. Together with increasing amounts of longitudinal data, it now is possible to study how the disease unfolds. This will transform the way AD is conceptualized, diagnosed, and treated.
Big Data For Better Outcomes
12 Mar 2017
Large amounts of data from multiple sources have led to the opportunity of deriving health benefits through using sophisticated technologies. Regardless of the frequently cited revolution of data-driven health care, promises remain to be fulfilled. The IMI2 BD4BO programme recognises this in representative disease areas, providing a framework to guide research and invite stakeholders to discuss the future of health systems shaped by big data. The projects will impact he research environment through shared definitions and methods to avoid duplication of work, while transforming health care systems in terms of clinical operations, research and development, evidence-based personalised medicine and public health.